Evidence map›Paper›PMID 18353770›Full record

ArticleThe Journal of biological chemistry2008

Inactivation of NuRD component Mta2 causes abnormal T cell activation and lupus-like autoimmune disease in mice.

Xiangdong Lu, Grigoriy I Kovalev, Hua Chang, Eric Kallin, Geoffrey Knudsen, Li Xia, Nilamadhab Mishra, Phillip Ruiz, En Li, Lishan Su and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Zfp281 and Zfp148 control CD4Science immunology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. DNA Methylation-Governed Gene Expression in Autoimmune Arthritis.International journal of molecular sciences · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Xiangdong LuHoward Hughes Medical Institute, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Grigoriy I Kovalev
Hua Chang
Eric Kallin
Geoffrey Knudsen
Li Xia
Nilamadhab Mishra
Phillip Ruiz
En Li
Lishan Su
Yi Zhang
University of North Carolina at Chapel Hill · USHoward Hughes Medical Institute · USUniversity of Miami · USWake Forest University · US

Funding

RHOA EFFECTOR IN HIV-1 REPLICATION AND PATHOGENESISR01AI048407 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SU, LISHAN · 2000 to 2004
$1.6M
Treg in HIV-1 Replication and PathogenesisR01AI077454 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SU, LISHAN · 2008 to 2011
$1.5M
Mechanism of Gene Silencing by DNA MethylationR01GM063067 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI ZHANG, YI · 2001 to 2005
$1.2M
Novel genetic approach to dissecting homing /engraftmentR21HL072240 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SU, LISHAN · 2002 to 2004
$651k
Modulation of HIV-1 Replication and T Cell Activation by FoxP3R56AI048407 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SU, LISHAN · 2007 to 2007
$363k
Howard Hughes Medical InstituteNHLBI NIH HHS HL72240NIAID NIH HHS AI48407NIAID NIH HHS R01 AI077454NIGMS NIH HHS GM63067
6 · The paper itself

Abstract

Dynamic changes in chromatin structure through ATP-dependent remodeling and covalent modifications on histones play important roles in transcription regulation. Among the many chromatin modifiers identified, the NuRD (nucleosome remodeling histone deacetylase) complex is unique because it possesses both nucleosome remodeling and histone deacetylase activities. To understand the biological function of the NuRD complex, we generated a knock-out mouse model of the Mta2 (metastasis-associated protein 2) gene, which encodes a NuRD-specific component. Mta2 null mice exhibited partial embryonic lethality. The surviving mice developed lupus-like autoimmune symptoms including skin lesions, bodyweight loss, glomerulonephritis, liver inflammation, and production of autoantibodies. Transplantation of bone marrow cells from Mta2 null mice recapitulated some of the symptoms including skin lesion and bodyweight loss in the recipient mice. Mta2 null T lymphocytes showed normal development but hyperproliferation upon stimulation, which correlates with hyperinduction of interleukin (IL)-2, IL-4, and interferon (IFN)-gamma. T cell hyperproliferation, but not other autoimmune symptoms, was observed in T cell-specific Mta2 knock-out mice. Mta2 null T cells produced more IL-4 and IFN-gamma under Th2 activation conditions, but normal levels of IL-4 and IFN-gamma under Th1 activation conditions. Furthermore, we found that IL-4 is a direct target gene of Mta2. Our study suggests that Mta2/NuRD is involved in modulating IL-4 and IFN-gamma expression in T cell immune responses, and gene expression in non-T cells plays an important role in controlling autoimmunity.

Indexed as

AllelesAnimalsCarrier ProteinsDisease Models, AnimalHistone DeacetylasesInflammationInterferon-gammaLupus Erythematosus, CutaneousLymphocyte ActivationMi-2 Nucleosome Remodeling and Deacetylase ComplexMiceMice, TransgenicModels, BiologicalModels, GeneticRepressor ProteinsT-LymphocytesCarrier ProteinsHistone DeacetylasesInterferon-gammaMi-2 Nucleosome Remodeling and Deacetylase ComplexMta2 protein, mouseRepressor ProteinsTrans-Activators

Identifiers

PMID18353770
PMCPMC2376246
OpenAlexW1968864956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.